Holen Sie sich die Stockscreener-App
604.86
0.59%
-3.58
Vorhandelsmarkt:
602.90
-1.96
-0.32%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt GS?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$608.44
Offen:
$608.52
24-Stunden-Volumen:
1.73M
Relative Volume:
0.60
Marktkapitalisierung:
$185.60B
Einnahmen:
$54.36B
Nettoeinkommen (Verlust:
$14.88B
KGV:
14.04
EPS:
43.09
Netto-Cashflow:
$-24.50B
1W Leistung:
+1.11%
1M Leistung:
+10.19%
6M Leistung:
-0.61%
1J Leistung:
+32.31%
1-Tages-Spanne:
$598.30
$610.00
1-Wochen-Bereich:
$582.50
$618.63
52-Wochen-Spanne:
$437.37
$672.19
Goldman Sachs Group Inc Stock (GS) Company Profile
Firmenname
Goldman Sachs Group Inc
Sektor
Branche
Telefon
212-902-1000
Adresse
200 WEST STREET, NEW YORK, NY
Vergleichen Sie GS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GS
Goldman Sachs Group Inc
|
604.86 | 183.56B | 54.36B | 14.88B | -24.50B | 43.09 |
|
MS
Morgan Stanley
|
128.16 | 202.56B | 59.92B | 14.29B | -30.33B | 8.52 |
|
SCHW
Charles Schwab Corp
|
87.76 | 158.64B | 20.47B | 6.49B | 9.79B | 3.30 |
|
FUTU
Futu Holdings Ltd Adr
|
107.36 | 15.52B | 1.74B | 697.91M | 251.35M | 4.9851 |
|
HOOD
Robinhood Markets Inc
|
63.95 | 57.16B | 3.26B | 1.59B | 1.06B | 1.76 |
Goldman Sachs Group Inc Stock (GS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-04-04 | Herabstufung | Daiwa Securities | Outperform → Neutral |
| 2025-03-19 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-02-27 | Herabstufung | Keefe Bruyette | Outperform → Mkt Perform |
| 2025-01-06 | Herabstufung | UBS | Buy → Neutral |
| 2024-11-26 | Herabstufung | HSBC Securities | Buy → Hold |
| 2024-07-02 | Herabstufung | Seaport Research Partners | Buy → Neutral |
| 2024-04-16 | Hochstufung | Argus | Hold → Buy |
| 2024-03-14 | Hochstufung | Daiwa Securities | Neutral → Outperform |
| 2024-02-27 | Eingeleitet | Edward Jones | Buy |
| 2024-01-30 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-01-18 | Bestätigt | BMO Capital Markets | Market Perform |
| 2024-01-10 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2023-09-07 | Eingeleitet | HSBC Securities | Buy |
| 2023-08-01 | Hochstufung | Atlantic Equities | Underweight → Neutral |
| 2023-07-25 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-07-24 | Bestätigt | UBS | Buy |
| 2023-07-13 | Hochstufung | Odeon | Hold → Buy |
| 2023-07-10 | Herabstufung | Societe Generale | Buy → Hold |
| 2023-04-19 | Bestätigt | BMO Capital Markets | Outperform |
| 2023-04-19 | Bestätigt | Evercore ISI | Outperform |
| 2023-04-19 | Bestätigt | JMP Securities | Mkt Outperform |
| 2023-04-19 | Bestätigt | JP Morgan | Overweight |
| 2023-04-19 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2023-04-19 | Bestätigt | Oppenheimer | Outperform |
| 2023-04-19 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2023-04-12 | Hochstufung | UBS | Neutral → Buy |
| 2023-02-08 | Bestätigt | Wells Fargo | Overweight |
| 2023-01-10 | Hochstufung | Odeon | Sell → Hold |
| 2023-01-04 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2022-10-07 | Hochstufung | Keefe Bruyette | Mkt Perform → Outperform |
| 2022-10-05 | Herabstufung | Atlantic Equities | Neutral → Underweight |
| 2022-09-06 | Herabstufung | Odeon | Hold → Sell |
| 2022-06-29 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-01-28 | Herabstufung | Odeon | Buy → Hold |
| 2022-01-06 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-12-06 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2021-10-05 | Bestätigt | JMP Securities | Mkt Outperform |
| 2021-07-07 | Fortgesetzt | Keefe Bruyette | Mkt Perform |
| 2021-06-09 | Eingeleitet | Jefferies | Buy |
| 2021-04-01 | Herabstufung | UBS | Buy → Neutral |
| 2021-01-06 | Eingeleitet | Daiwa Securities | Outperform |
| 2021-01-04 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-11-30 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2020-09-24 | Hochstufung | UBS | Neutral → Buy |
| 2020-07-08 | Eingeleitet | Seaport Global Securities | Buy |
| 2020-06-23 | Bestätigt | UBS | Buy |
| 2020-06-04 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2020-06-02 | Bestätigt | Wells Fargo | Overweight |
| 2020-05-26 | Hochstufung | Odeon | Hold → Buy |
| 2020-05-15 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2020-04-14 | Hochstufung | Societe Generale | Sell → Buy |
| 2020-04-02 | Herabstufung | DA Davidson | Buy → Neutral |
| 2020-03-26 | Hochstufung | Berenberg | Sell → Hold |
| 2020-02-03 | Herabstufung | Odeon | Buy → Hold |
| 2020-01-16 | Hochstufung | Odeon | Hold → Buy |
| 2020-01-13 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2020-01-09 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-01-09 | Eingeleitet | DA Davidson | Buy |
| 2019-12-16 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-09-05 | Herabstufung | Odeon | Buy → Hold |
| 2019-07-26 | Hochstufung | Keefe Bruyette | Mkt Perform → Outperform |
| 2019-02-01 | Herabstufung | Societe Generale | Hold → Sell |
Alle ansehen
Goldman Sachs Group Inc Aktie (GS) Neueste Nachrichten
SALESFORCE : Goldman Sachs gives a Buy rating - marketscreener.com
Ex-Goldman banker Leissner sentenced to two years in prison in 1MDB case - Reuters
Two-year prison sentence for ex-Goldman banker Leissner in 1MDB case 'too short', Malaysia minister says - marketscreener.com
Goldman Sachs Initiates Coverage on Insulet (PODD) with Positive Outlook | PODD Stock News - GuruFocus
Goldman Sachs (GS) Stock Dips While Market Gains: Key Facts - sharewise
Apollo Teams Up With JPMorgan, Goldman to Trade Private Credit - Bloomberg.com
Goldman Sachs sends message on what may happen next in the trade war - TheStreet
Goldman Letter Helps Sway Judge Who Sent Leissner to Prison - Bloomberg.com
Goldman Sachs Adjusts Price Target for Bath & Body Works (BBWI) | BBWI Stock News - GuruFocus
Ex-Goldman Sachs banker gets 2 years in prison for plot to fleece billions from Malaysia’s 1MDB fund - KLAS 8 News Now
Goldman, Morgan Stanley Say Trump Can Deploy Other Tariff Tools - Rigzone
Here's How Much $100 Invested In Goldman Sachs Group 5 Years Ago Would Be Worth Today - Benzinga
Acadia Pharmaceuticals to Participate in the Goldman Sachs 46th - GuruFocus
Acadia Pharmaceuticals to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference - Yahoo Finance
Premium Travel Demand Gives Airlines, Hotels And Cruises An Edge in 2025: Goldman Sachs - Benzinga
Immuno-Dermatology Leader Arcutis Set for Key Goldman Sachs Healthcare Conference Presentation - Stock Titan
Form 424B2 GOLDMAN SACHS GROUP INC - StreetInsider
Ex-Goldman Banker Leissner Gets Two Years in 1MDB Fraud Case - Bloomberg.com
Ex-Goldman Banker Leissner Gets Two Years in 1MDB Fraud Case (3) - Bloomberg Law News
The Goldman Sachs Group Raises StepStone Group (NASDAQ:STEP) Price Target to $63.00 - MarketBeat
The Goldman Sachs Group Raises Okta (NASDAQ:OKTA) Price Target to $137.00 - MarketBeat
Goldman Sachs Upgrades First Solar Price Target to $255 (Ready for Inan) - Yahoo Finance
US judge sentences ex-Goldman Sachs banker to two years over 1MDB scandal - El Paso Inc.
Goldman Sachs says deal outlook is good, but timing is uncertain - Reuters
Ex-Goldman Partner, Star Witness Against 1MDB Gets 2 Years - Law360
Apollo Global, JPMorgan, Goldman Sachs Working With Other Banks to Trade Private Credit - marketscreener.com
Ex-Goldman banker gets two-year sentence for 1MDB rolereport - Seeking Alpha
Goldman’s Waldron Says Bond Traders Fear Debt More Than Tariffs - Bloomberg.com
Former Goldman Sachs Executive Who Cooperated With Prosecutors in Malaysia Bribe Scheme Gets Prison Term - Law.com
Ex-Goldman Banker Leissner Gets Two Years for Role in 1MDB Fraud - Bloomberg.com
Ex-Goldman Banker Sentenced to 2 Years in 1MDB Bribery Scandal - WSJ
Transcript : The Goldman Sachs Group, Inc. Presents at Bernstein 41st Annual Strategic Decisions Conference 2025, May-29-2025 09 - marketscreener.com
CRM: Salesforce Price Target Raised by Goldman Sachs | CRM Stock News - GuruFocus
Goldman Sachs Reinstates Sell Rating on DBVT with Price Target of $7.25 | DBVT Stock News - GuruFocus
Goldman Says Trump Can Offset Tariff Ruling With Other Tools - Bloomberg.com
Rare Disease Innovator Fulcrum Therapeutics Takes Stage at Elite Goldman Sachs Healthcare Conference - Stock Titan
Salesforce price target raised to $385 from $340 at Goldman Sachs - TipRanks
DSG Capital Advisors LLC Purchases Shares of 22,086 The Goldman Sachs Group, Inc. (NYSE:GS) - MarketBeat
Lansforsakringar Fondforvaltning AB publ Acquires New Holdings in The Goldman Sachs Group, Inc. (NYSE:GS) - MarketBeat
Northstar Financial Companies Inc. Buys New Shares in The Goldman Sachs Group, Inc. (NYSE:GS) - MarketBeat
BioStem Technologies to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference - GlobeNewswire
BioStem Technologies' Advanced Wound Care Innovation Takes Spotlight at Goldman Sachs Healthcare Conference - Stock Titan
The Goldman Sachs Group, Inc. (NYSE:GS) Holdings Cut by Mattson Financial Services LLC - MarketBeat
Goldman Sachs Adjusts Price Target on HP to $26 From $27, Maintains Neutral Rating - marketscreener.com
Companies turn to private credit during tariff turmoil for loans - marketscreener.com
Goldman Sachs cuts HP stock price target to $26 from $33 - Investing.com India
Goldman Sachs raises nCino stock price target to $27 By Investing.com - Investing.com India
Goldman Sachs maintains Buy on e.l.f. Beauty, price target at $120 - Investing.com India
Goldman Sachs Adjusts Price Target on Salesforce to $385 From $340, Maintains Buy Rating - marketscreener.com
Goldman Sachs Sets Neutral Rating for BioNTech (BNTX) with $110 Target | BNTX Stock News - GuruFocus
Goldman Sachs lifts Salesforce stock target to $385, maintains buy By Investing.com - Investing.com UK
Finanzdaten der Goldman Sachs Group Inc-Aktie (GS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
0.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):